Implications of the cardiac arrhythmia suppression trial for antiarrhythmic drug treatment
- 20 February 1990
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 65 (8) , 3-10
- https://doi.org/10.1016/0002-9149(90)91410-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Cardiac Arrhythmia Suppression Trial (CAST)New England Journal of Medicine, 1989
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Arrhythmogenic effects of antiarrhythmic drugs: A study of 506 patients treated for ventricular tachycardia or fibrillationJournal of the American College of Cardiology, 1989
- Clinical Characteristics of Patients with Ventricular Fibrillation during Antiarrhythmic Drug TherapyNew England Journal of Medicine, 1988
- Clinical types of proarrhythmic response to antiarrhythmic drugsThe American Journal of Cardiology, 1987
- Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: Evaluation in a conscious canine model of sudden deathJournal of the American College of Cardiology, 1987
- Influence of left ventricular dysfunction on flecainide therapyJournal of the American College of Cardiology, 1987
- Application of a frequency definition of ventricular proarrhythmiaThe American Journal of Cardiology, 1987
- Effects of Flecainide Acetate on Ventricular Tachyarrhythmia and Fibrillation in Dogs with Recent Myocardial InfarctionPharmacology, 1987
- Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.Circulation, 1982